S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.33%) $10.88
USD/GBP
(-0.01%) $0.792
USD/RUB
(-0.97%) $91.68

Realtime updates for Certara, Inc. [CERT]

Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
BUY
66.67%
return 7.50%
SELL
60.00%
return -1.75%
Last Updated28 Mar 2024 @ 16:00

1.48% $ 17.88

SELL 62545 min ago

@ $17.66

Issued: 14 Feb 2024 @ 13:37


Return: 1.25%


Previous signal: Feb 14 - 12:03


Previous signal: Buy


Return: 1.15 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access...

Stats
Today's Volume 618 320
Average Volume 527 642
Market Cap 2.86B
EPS $0 ( 2024-02-29 )
Next earnings date ( $0.100 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -51.09
ATR14 $0.0320 (0.18%)
Insider Trading
Date Person Action Amount type
2024-03-05 Traynor Richard M. Buy 10 765 Common Stock
2024-03-05 Traynor Richard M. Sell 3 660 Common Stock
2024-03-05 Sherman Nicolette D Buy 6 600 Common Stock
2024-03-05 Sherman Nicolette D Sell 2 373 Common Stock
2024-03-05 Pedersen Leif E Buy 15 548 Common Stock
INSIDER POWER
-93.23
Last 96 transactions
Buy: 656 854 | Sell: 30 641 634

Volume Correlation

Long: -0.28 (neutral)
Short: 0.69 (moderate)
Signal:(49.277) Neutral

Certara, Inc. Correlation

10 Most Positive Correlations
RELY0.963
MSAC0.958
KAII0.953
ALTR0.951
APXI0.95
LMB0.946
AEAC0.945
ANSS0.944
MLAI0.944
DSEY0.943
10 Most Negative Correlations
GOOD-0.959
CSSEP-0.958
HALO-0.955
CBNK-0.952
SFST-0.947
WASH-0.947
WTBA-0.946
MCBS-0.946
UTHR-0.946
BMRA-0.945

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Certara, Inc. Correlation - Currency/Commodity

The country flag 0.53
( weak )
The country flag 0.21
( neutral )
The country flag 0.00
( neutral )
The country flag 0.12
( neutral )
The country flag 0.00
( neutral )
The country flag 0.40
( neutral )

Certara, Inc. Financials

Annual 2023
Revenue: $354.34M
Gross Profit: $167.79M (47.35 %)
EPS: $-0.350
Q4 2023
Revenue: $88.01M
Gross Profit: $41.83M (47.53 %)
EPS: $-0.0781
Q3 2023
Revenue: $85.58M
Gross Profit: $49.70M (58.08 %)
EPS: $-0.310
Q2 2023
Revenue: $90.45M
Gross Profit: $54.23M (59.95 %)
EPS: $0.0300

Financial Reports:

No articles found.

Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators